Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
Source: shutterstock.com/Champhei Abeona Therapeutics (NASDAQ:ABEO) stock is falling on Tuesday after getting a Complete Response Letter (CRL) from the Food and Drug Administration (FDA). The CRL from the FDA notes that the regulator needs additional …